ROS and protein oxidation in early stages of cytotoxic drug induced apoptosis

被引:28
作者
England, Karen [1 ]
Driscoll, Carolyn O. [1 ]
Cotter, Thomas G. [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Biosci Inst, Cork, Ireland
关键词
post-translational modifications; proteomics; apoptosis; carbonylation; ER stress; leukaemia;
D O I
10.1080/10715760600838209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytotoxic drugs induce cell death through induction of apoptosis. This can be due to activation of a number of cell death pathways. While the downstream events in drug induced cell death are well understood, the early events are less clear. We therefore used a proteomic approach to investigate the early events in apoptosis induced by a variety of drugs in HL60 cells. Using 2D-gel electrophoresis, we were able to identify a number of protein changes that were conserved between different drug treatments. Identification of post-translational modifications (PTM) responsible for these proteome changes revealed an increase in protein oxidation in drug treated cells, as well as changes in protein phosphorylation. We demonstrate an accumulation of oxidised proteins within the ER, which lead to ER stress and calcium release and may result in the induction of apoptosis. This study demonstrates the importance of ROS mediated protein modifications in the induction of the early stages of apoptosis in response to chemotherapeutic drug treatment.
引用
收藏
页码:1124 / 1137
页数:14
相关论文
共 52 条
  • [21] Cellular stress response and apoptosis in cancer therapy
    Herr, I
    Debatin, KM
    [J]. BLOOD, 2001, 98 (09) : 2603 - 2614
  • [22] Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases
    Kang, YJ
    Zhou, ZX
    Wang, GW
    Buridi, A
    Klein, JB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) : 13690 - 13698
  • [23] Requirement of caspase and p38MAPK activation in zinc-induced apoptosis in human leukemia HL-60 cells
    Kondoh, M
    Tasaki, E
    Araragi, S
    Takiguchi, M
    Higashimoto, M
    Watanabe, Y
    Sato, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (24): : 6204 - 6211
  • [24] LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
  • [25] LOWN JW, 1982, BIOCHEM PHARMACOL, V31, P575
  • [26] The role of the unfolded protein response in tumour development: Friend or foe?
    Ma, YJ
    Hendershot, LM
    [J]. NATURE REVIEWS CANCER, 2004, 4 (12) : 966 - 977
  • [27] Oxidative modification of glutamine synthetase by 2,2′-azobis(2-amidinopropane) dihydrochloride
    Ma, YS
    Chao, CC
    Stadtman, ER
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 363 (01) : 129 - 134
  • [28] Anti-oxidants and apoptosis
    McGowan, AJ
    Fernandes, RS
    Samali, A
    Cotter, TG
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (01) : 229 - 233
  • [29] Nitric oxide can inhibit apoptosis or switch it into necrosis
    Melino, G
    Catani, MV
    Corazzari, M
    Guerrieri, P
    Bernassola, F
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (04) : 612 - 622
  • [30] S-nitrosylation regulates apoptosis
    Melino, G
    Bernassola, F
    Knight, RA
    Corasaniti, MT
    Nistico, G
    FinazziAgro, A
    [J]. NATURE, 1997, 388 (6641) : 432 - 433